Home › Macular Degeneration › Florida › Pensacola
Macular Degeneration clinical trials in Pensacola, FL
5 studies for Macular Degeneration are looking for participants at sites in and around Pensacola (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RecruitingPhase 2/3
- Retina Specialty Institute, Pensacola
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
RecruitingPhase 2
- Retina Specialty Institute, Pensacola
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
RecruitingPhase 1
- Retina Specialty Institute, Pensacola
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
RecruitingPhase 1/2
- Retinal Specialty Institute, Pensacola
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
RecruitingPhase 3
- Retina Specialty Institute, Pensacola
About Macular Degeneration
Macular degeneration, or age-related macular degeneration (AMD), causes vision loss in older adults. Learn about the types and what can help.
More about Macular Degeneration on MedlinePlus
Macular Degeneration trials in other cities
- Dallas, TX13 studies
- Erie, PA10 studies
- The Woodlands, TX9 studies
- Hagerstown, MD8 studies
- Reno, NV8 studies
- Sacramento, CA8 studies
- Houston, TX7 studies
- Fort Worth, TX7 studies
- Santa Monica, CA7 studies
- Carmel, IN7 studies
- Boston, MA7 studies
- Cleveland, OH7 studies
Other studies in Pensacola
- Obesity6 studies
- Heart Failure6 studies
- Cardiovascular Disease5 studies
- Atrial Fibrillation5 studies
- Burkitt Lymphoma4 studies
- Overweight4 studies
- Geographic Atrophy3 studies
- Non-Small Cell Lung Cancer3 studies
- Ulcerative Colitis3 studies
- Crohn's Disease3 studies
- Acute Biphenotypic Leukemia3 studies
- Acute Myeloid Leukemia3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.